ECRG4 and infection: Following cutaneous infection with USA300 LAC:Lux, we found that bacteria rapidly proliferated in the ECRG4 KO infection, with flux peaking at day 2, while the WT mouse was able to limit early proliferation, demonstrating declining burden from day 1 (Fig 1E).